Purpose

This study hypothesizes that temporary bilateral uterine and utero-ovarian artery occlusion with laparoscopic clamps at time of minimally invasive myomectomy will lead to a decreased blood loss at time of myomectomy compared to minimally invasive myomectomy without temporary occlusion.

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Patient undergoing minimally invasive myomectomy with either a single intramural or Submucosal fibroid =/>5cm or - Patients undergoing minimally invasive Myomectomy with =/> 5 fibroids

Exclusion Criteria

  • Pregnancy, - Age <18yo, - Patients undergoing concomitant surgery such as endometriosis surgery, - Suspected malignancy

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Temporary vessel clamps
Use of temporary laparoscopic vessel clamps on uterine and ovarian vessels
  • Other: Temporary clamping of uterine and ovarian vessels
    Surgeon will temporarily clamp uterine and ovarian vessels.
    Other names:
    • Vessel occlusion
No Intervention
No Temporary vessel clamps
No use of vessel clamps

Recruiting Locations

Memorial Hermann Hospital
Houston, Texas 77030
Contact:
Randa Jalloul, MD
713-486-7700
randa.j.jalloul@uth.tmc.edu

More Details

Status
Recruiting
Sponsor
The University of Texas Health Science Center, Houston

Study Contact

Randa Jalloul, MD
3137128603
randa.j.jalloul@uth.tmc.edu

Detailed Description

Background: Leiomyomas are the most common benign tumor of the uterus and affect approximately 70-80% of the population with a uterus . Patients who opt to undergo treatment for a fibroid uterus have a variety of options including medical management, embolization, or surgical management; Historically surgical management involved hysterectomy; however, myomectomy has become more popular as a uterine sparing option. Current data supports that minimally invasive myomectomy is associated with lower morbidity and blood loss than traditional abdominal surgery. With advances in Minimally invasive myomectomy (MIS). There continues to be interest in methods to better improve intraoperative and postoperative outcomes. There is currently support for universal use of intramural vasopressin at time of myomectomy and a growing body of evidence to support temporary bilateral occlusion of the uterine and/or uteroovarian arteries at time of myomectomy to decrease blood loss. High myoma burden is associated with an increased blood loss at time of surgical management. Previous studies assessing the utility in temporary occlusion of the uterine and/or utero-ovarian vessels have not specifically evaluated the impact on high myoma burden individuals. As higher myoma burden is addressed in a minimally invasive fashion, it is important to specifically evaluate techniques to optimize these procedures. This study will specifically evaluate the effect of temporary bilateral uterine artery and utero-ovarian occlusion with laparoscopic clamps at the time of minimally invasive myomectomy.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.